mTOR and MAPK signaling by traditional Chinese medicine in gastric cancer

(Multiomics OR Omics) AND (Lung OR gastric OR Hepatocellular)

By: Lujia Chen · Guonong He · Hongfei Liu

13 March 2026 at 18:00

Tissue Cell. 2026 Mar 10;101:103409. doi: 10.1016/j.tice.2026.103409. Online ahead of print.

ABSTRACT

Gastric cancer (GC) remains a major global health burden, with high incidence and mortality rates, particularly in East Asia, driven by factors such as Helicobacter pylori infection, dietary risks, and genetic predispositions. Conventional treatments like surgery and chemotherapy are limited by resistance, toxicity, and poor outcomes in advanced stages. The PI3K/Akt/mTOR and MAPK signaling pathways are central to GC pathogenesis, promoting proliferation, survival, metabolic reprogramming, epithelial-mesenchymal transition (EMT), and metastasis through aberrations like PIK3CA mutations, PTEN loss, and KRAS alterations. These pathways exhibit extensive crosstalk, contributing to therapeutic resistance. This review explores the regulatory effects of Traditional Chinese Medicine (TCM) on these pathways in GC, grounded in TCM principles such as Qi deficiency, Damp-Heat, and disharmony of the Spleen and Stomach. Single herbal monomers (e.g., curcumin, berberine, resveratrol) inhibit PI3K/Akt/mTOR by upregulating PTEN and suppressing mTOR, inducing autophagy and apoptosis. Classical herbs like Huangqin and Huanglian modulate Akt and ERK phosphorylation, while compound formulas (e.g., Banxia Xiexin Decoction, Sijunzi Decoction) synergistically target both pathways, reversing EMT and chemoresistance. TCM addresses crosstalk by disrupting feedback loops and reducing inflammation, enhancing efficacy in combination with Western therapies like chemotherapy and immunotherapy. Network pharmacology and multi-omics analyses reveal TCM's multitarget mechanisms, aligning with ZHENG-based personalization. Challenges include research variability, standardization issues, and incomplete mechanistic validation. Future directions emphasize high-quality trials, omics integration, and precision TCM for clinical translation. TCM offers low-toxicity, holistic options for integrative GC management, potentially improving survival and quality of life.

PMID:41825157 | DOI:10.1016/j.tice.2026.103409

Autophagy-centered regulation of PI3K/Akt/mTOR and MAPK signaling by traditional Chinese medicine in gastric cancer

Omics in Gastric

By: Lujia Chen · Guonong He · Hongfei Liu

13 March 2026 at 18:00

Tissue Cell. 2026 Mar 10;101:103409. doi: 10.1016/j.tice.2026.103409. Online ahead of print.

ABSTRACT

Gastric cancer (GC) remains a major global health burden, with high incidence and mortality rates, particularly in East Asia, driven by factors such as Helicobacter pylori infection, dietary risks, and genetic predispositions. Conventional treatments like surgery and chemotherapy are limited by resistance, toxicity, and poor outcomes in advanced stages. The PI3K/Akt/mTOR and MAPK signaling pathways are central to GC pathogenesis, promoting proliferation, survival, metabolic reprogramming, epithelial-mesenchymal transition (EMT), and metastasis through aberrations like PIK3CA mutations, PTEN loss, and KRAS alterations. These pathways exhibit extensive crosstalk, contributing to therapeutic resistance. This review explores the regulatory effects of Traditional Chinese Medicine (TCM) on these pathways in GC, grounded in TCM principles such as Qi deficiency, Damp-Heat, and disharmony of the Spleen and Stomach. Single herbal monomers (e.g., curcumin, berberine, resveratrol) inhibit PI3K/Akt/mTOR by upregulating PTEN and suppressing mTOR, inducing autophagy and apoptosis. Classical herbs like Huangqin and Huanglian modulate Akt and ERK phosphorylation, while compound formulas (e.g., Banxia Xiexin Decoction, Sijunzi Decoction) synergistically target both pathways, reversing EMT and chemoresistance. TCM addresses crosstalk by disrupting feedback loops and reducing inflammation, enhancing efficacy in combination with Western therapies like chemotherapy and immunotherapy. Network pharmacology and multi-omics analyses reveal TCM's multitarget mechanisms, aligning with ZHENG-based personalization. Challenges include research variability, standardization issues, and incomplete mechanistic validation. Future directions emphasize high-quality trials, omics integration, and precision TCM for clinical translation. TCM offers low-toxicity, holistic options for integrative GC management, potentially improving survival and quality of life.

PMID:41825157 | DOI:10.1016/j.tice.2026.103409

Efficient Agent Training for Computer Use

cs.AI, q-bio.NC updates on arXiv.org

By: Yanheng He · Jiahe Jin · Pengfei Liu

4 March 2026 at 13:00

arXiv:2505.13909v2 Announce Type: replace Abstract: Scaling up high-quality trajectory data has long been a critical bottleneck for developing human-like computer use agents. We introduce PC Agent-E, an efficient agent training framework that significantly reduces reliance on large-scale human demonstrations. Starting with just 312 human-annotated computer use trajectories, we further augment them by synthesizing diverse alternative action decisions with Claude 3.7 Sonnet. Trained on these enriched trajectories, our PC Agent-E model achieved a remarkable 141 relative improvement, and even surpassed the Claude 3.7 Sonnet by 10% in relative terms on WindowsAgentArena-V2, an improved benchmark we also released. By integrating robust human computer use skills with automated AI data synthesis capabilities, our method not only brought substantial improvements over training on human trajectories alone, but also significantly surpassed direct distillation from Claude 3.7 Sonnet. Code, data and models are available at https://github.com/GAIR-NLP/PC-Agent-E

Mantis: A Versatile Vision-Language-Action Model with Disentangled Visual Foresight

cs.AI, q-bio.NC updates on arXiv.org

By: Yi Yang · Xueqi Li · Yiyang Chen · Jin Song · Yihan Wang · Zipeng Xiao · Jiadi Su · You Qiaoben · Pengfei Liu · Zhijie Deng

24 February 2026 at 13:00

arXiv:2511.16175v2 Announce Type: replace-cross Abstract: Recent advances in Vision-Language-Action (VLA) models demonstrate that visual signals can effectively complement sparse action supervisions. However, letting VLA directly predict high-dimensional visual states can distribute model capacity and incur prohibitive training cost, while compressing visual states into more compact supervisory signals inevitably incurs information bottlenecks. Moreover, existing methods often suffer from poor comprehension and reasoning capabilities due to the neglect of language supervision. This paper introduces Mantis, a novel framework featuring a Disentangled Visual Foresight (DVF) to tackle these issues. Specifically, Mantis decouples visual foresight prediction from the backbone with the combination of meta queries and a diffusion Transformer (DiT) head. With the current visual state provided to the DiT via a residual connection, a simple next-state prediction objective enables the meta queries to automatically capture the latent actions that delineate the visual trajectory, and hence boost the learning of explicit actions. The disentanglement reduces the burden of the VLA backbone, enabling it to maintain comprehension and reasoning capabilities through language supervision. Empirically, pretrained on human manipulation videos, robot demonstrations, and image-text pairs, Mantis achieves a 96.7% success rate on LIBERO benchmark after fine-tuning, surpassing powerful baselines while exhibiting high convergence speed. Real-world evaluations show that Mantis outperforms $\pi_{0.5}$, a leading open-source VLA model, particularly in instruction-following capability, generalization to unseen instructions, and reasoning ability. Code and weights are released to support the open-source community.

Reading view